Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pasithea Therapeutics Corp
(NQ:
KTTA
)
5.050
+0.390 (+8.37%)
Streaming Delayed Price
Updated: 3:41 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pasithea Therapeutics Corp
< Previous
1
2
3
4
5
6
7
Next >
Nasdaq Sharply Lower as Tech Selloff Weighs
November 23, 2021
The Nasdaq Composite is sharply lower midday, as the tech selloff weighs on the benchmark, while the Dow Jones Industrial Average is up roughly 35 points, and the S&P 500 sits modestly in the red.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
36 Stocks Moving In Tuesday's Mid-Day Session
November 23, 2021
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares jumped 216.6% to $7.00 after the company announced its subsidiary Pasithea Clinics has been approved to provide...
Via
Benzinga
DKS Stock: 14 Reasons Why Dick’s Sporting Goods Investors Are Taking an L Today
November 23, 2021
Dick's Sporting Goods (DKS) stock isn't doing so hot on Tuesday following the release of its earnings report for the third quarter of 2021.
Via
InvestorPlace
PTPI Stock: 11 Things to Know About Penny Stock Petros Pharmaceuticals as Shares Rocket 100%+
November 23, 2021
Petros Pharmaceuticals (PTPI) stock is surging higher on Tuesday following a filing with the U.S. Securities and Exchange Commission (SEC).
Via
InvestorPlace
DLTR Stock Alert: The Dollar Tree Price Hike Giving Shares a Bump Today
November 23, 2021
Dollar Tree (DLTR) stock is heading higher Tuesday after the company saw positive results from its recent price increase tests.
Via
InvestorPlace
KTTA Stock: The Depression Nasal Spray News That Has Pasithea Therapeutics Investors Ecstatic Today
November 23, 2021
Pasithea Therapeutics (KTTA) stock is rocketing higher on Tuesday after adding esketamine nasal spray to its U.K. offerings.
Via
InvestorPlace
Mid-Morning Market Update: Markets Mostly Lower; Best Buy Posts Upbeat Q3 Earnings
November 23, 2021
Following the market opening Tuesday, the Dow traded up 0.02% to 35,627.53 while the NASDAQ fell 0.58% to 15,762.28. The S&P also fell, dropping 0.14% to 4,676.49. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression
November 23, 2021
Palm Beach, FL –November 23, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global antidepressant market....
Via
FinancialNewsMedia
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 23, 2021
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 157.46% to $5.69 during Tuesday's pre-market session. The company's market cap stands at $75.1...
Via
Benzinga
EXCLUSIVE: Pasithea's Depression Treatment, Esketamine Nasal Spray Added In Clinic Offerings In UK
November 23, 2021
Pasithea Therapeutics Corp's (NASDAQ: KTTA) wholly-owned subsidiary, Pasithea Clinics, has been approved to provide esketamine nasal spray (Spravato) for treatment-resistant...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 22, 2021
Gainers Qualigen Therapeutics (NASDAQ:QLGN
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
November 18, 2021
Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 18, 2021
Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) stock increased by 78.28% to $37.94 during Thursday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
Mobile Mental Health: Coming to a Home Near You?
November 18, 2021
Photo by Anna Shvets from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 18, 2021
Good morning, investor! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
24 Stocks Moving in Thursday's Pre-Market Session
November 18, 2021
Gainers Sono Group N.V. (NASDAQ: SEV) rose 33% to $50.80 in pre-market trading. Sono Group shares climbed 155% on Wednesday after the company priced its IPO at $15 per share....
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Use of Ketamine for Mental Disorders Rising While New Therapies Emerge
November 17, 2021
Palm Beach, FL –November 17, 2021 – FinancialNewsMedia.com News Commentary – The uses of Ketamine for a variety of therapies are growing. An expanding number of clinics are offering ketamine infusion...
Via
FinancialNewsMedia
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 17, 2021
Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The company's market cap stands at $66.5 million. The...
Via
Benzinga
EXCLUSIVE: Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy In Major US Cities
November 17, 2021
Pasithea Therapeutics Corp. (NASDAQ:KTTA), a biotechnology...
Via
Benzinga
This Company Wants To Deliver Better Mental Health Straight to Your Door
November 10, 2021
Photo by Thirdman from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...
Via
Benzinga
Knock, Knock: It's 2021, and Mental Health Is at Your Door
November 05, 2021
Photo by Mo on Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...
Via
Benzinga
64 Biggest Movers From Yesterday
November 02, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 01, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
Pasithea and Evotec Team Up — Attempt to Make Headway on Brain Disorders
November 01, 2021
Photo by Karolina Grabowska from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 28, 2021
Gainers Medigus (NASDAQ:MDGS) shares moved upwards by 12.04% to $1.62 during Thursday's pre-market session. The market value of their outstanding shares is at $38.6...
Via
Benzinga
30 Stocks Moving in Thursday's Pre-Market Session
October 28, 2021
Gainers InflaRx N.V. (NASDAQ: IFRX) rose 47.9% to $4.23 in pre-market trading. Raymond James upgraded InflaRx from Outperform to Strong Buy and announced a $14 price target....
Via
Benzinga
Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety
October 27, 2021
Image by 3D Animation Production Company from Pixabay The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team...
Via
Benzinga
Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention
October 27, 2021
Palm Beach, FL –October 27, 2021 – FinancialNewsMedia.com News Commentary – Among the race to see what psychedelic drugs can do, ketamine is a step ahead of all other drugs, because it has already been...
Via
FinancialNewsMedia
Exposures
Product Safety
Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy
October 27, 2021
-- Pasithea Clinics commences IV ketamine infusion therapy in Knightsbridge, London, for the treatment of mental health disorders -- Miami Beach, FL / October 27, 2021 --...
Via
Benzinga
EXCLUSIVE: Pasithea Administers First IV Ketamine Infusion Therapy In Depression Patients
October 27, 2021
Pasithea Therapeutics Corp's (NASDAQ:KTTA) who...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.